| Toward the estimation of the absolute quality of individual protein structure models P Benkert, M Biasini, T Schwede Bioinformatics 27 (3), 343-350, 2011 | 2322 | 2011 |
| Protein structure homology modeling using SWISS-MODEL workspace L Bordoli, F Kiefer, K Arnold, P Benkert, J Battey, T Schwede Nature protocols 4 (1), 1-13, 2009 | 1402 | 2009 |
| QMEAN: A comprehensive scoring function for model quality assessment P Benkert, SCE Tosatto, D Schomburg Proteins: Structure, Function, and Bioinformatics 71 (1), 261-277, 2008 | 1123 | 2008 |
| QMEAN server for protein model quality estimation P Benkert, M Künzli, T Schwede Nucleic acids research 37 (suppl_2), W510-W514, 2009 | 885 | 2009 |
| Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ... Annals of neurology 81 (6), 857-870, 2017 | 795 | 2017 |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis C Barro, P Benkert, G Disanto, C Tsagkas, M Amann, Y Naegelin, ... Brain 141 (8), 2382-2391, 2018 | 358 | 2018 |
| Serum neurofilament light levels in normal aging and their association with morphologic brain changes M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ... Nature communications 11 (1), 812, 2020 | 258 | 2020 |
| Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors D Wild, JB Bomanji, P Benkert, H Maecke, PJ Ell, JC Reubi, ME Caplin Journal of Nuclear Medicine 54 (3), 364-372, 2013 | 222 | 2013 |
| QMEANclust: estimation of protein model quality by combining a composite scoring function with structural density information P Benkert, T Schwede, SCE Tosatto BMC structural biology 9, 1-17, 2009 | 184 | 2009 |
| Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation D Conen, N Rodondi, A Müller, JH Beer, P Ammann, G Moschovitis, ... Journal of the American College of Cardiology 73 (9), 989-999, 2019 | 146 | 2019 |
| Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ... The Lancet Neurology 21 (3), 246-257, 2022 | 119 | 2022 |
| Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years E Cantó, C Barro, C Zhao, SJ Caillier, Z Michalak, R Bove, D Tomic, ... JAMA neurology 76 (11), 1359-1366, 2019 | 118 | 2019 |
| Heart failure therapy–induced early ST2 changes may offer long-term therapy guidance T Breidthardt, C Balmelli, R Twerenbold, T Mosimann, J Espinola, P Haaf, ... Journal of cardiac failure 19 (12), 821-828, 2013 | 116 | 2013 |
| Prodromal symptoms of multiple sclerosis in primary care G Disanto, C Zecca, S MacLachlan, R Sacco, L Handunnetthi, UC Meier, ... Annals of neurology 83 (6), 1162-1173, 2018 | 107 | 2018 |
| Blood neurofilament light levels segregate treatment effects in multiple sclerosis B Delcoigne, A Manouchehrinia, C Barro, P Benkert, Z Michalak, ... Neurology 94 (11), e1201-e1212, 2020 | 91 | 2020 |
| Global and local model quality estimation at CASP8 using the scoring functions QMEAN and QMEANclust P Benkert, SCE Tosatto, T Schwede Proteins: Structure, Function, and Bioinformatics 77 (S9), 173-180, 2009 | 72 | 2009 |
| Serum neurofilament light chain levels in the intensive care unit: comparison between severely ill patients with and without coronavirus disease 2019 R Sutter, L Hert, GM De Marchis, R Twerenbold, L Kappos, Y Naegelin, ... Annals of Neurology 89 (3), 610-616, 2021 | 65 | 2021 |
| Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis A Manouchehrinia, P Stridh, M Khademi, D Leppert, C Barro, Z Michalak, ... Neurology 94 (23), e2457-e2467, 2020 | 54 | 2020 |
| Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing–remitting multiple sclerosis J Lorscheider, P Benkert, C Lienert, P Hänni, T Derfuss, J Kuhle, ... Multiple Sclerosis Journal 24 (6), 777-785, 2018 | 47 | 2018 |
| Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma FS Lehmann, F Trapani, I Fueglistaler, LM Terracciano, M von Flüe, ... World journal of gastroenterology: WJG 20 (17), 4994, 2014 | 43 | 2014 |
